Design and Development of Theranostic Nanomedicines - Nanotechnology for Biomedical Imaging and Diagnostics - page 446

[8] Tran ph, Tran TT, vo Tv, lee BJ. promising iron oxide-based magnetic nanoparticles in
biomedical engineering. arch pharm res 2012; 35 :2045-2061.
[9] sanvicens n, Marco Mp. Multifunctional nanoparticles—properties and prospects for
their use in human medicine. Trends Biotechnol 2008; 26 :425-433.
[10] Cai W, Chen X. Multimodality molecular imaging of tumor angiogenesis. J nucl Med
2008; 49 (suppl 2):113s-128s.
[11] Chen K, Xie J, Xu h, Behera D, Michalski Mh, Biswal s, Wang a, Chen X. Triblock
copolymer coated iron oxide nanoparticle conjugate for tumor integrin targeting.
Biomaterials 2009; 30 :6912-6919.
[12] lee hY, li Z, Chen K, hsu ar, Xu C, Xie J, sun s, Chen X. peT/Mri dual-modality
tumor imaging using arginine-glycine-aspartic (rgD)-conjugated radiolabeled iron
oxide nanoparticles. J nucl Med 2008; 49 :1371-1379.
[13] Xie J, Chen K, huang J, lee s, Wang J, gao J, li X, Chen X. peT/nirF/Mri triple
functional iron oxide nanoparticles. Biomaterials 2010; 31 :3016-3022.
[14] Xie J, lee s, Chen X. nanoparticle-based theranostic agents. adv Drug Deliv rev
2010; 62 :1064-1079.
[15] Kohler n, sun C, Wang J, Zhang M. Methotrexate-modified superparamagnetic
nanoparticles and their intracellular uptake into human cancer cells. langmuir
2005; 21 :8858-8864.
[16] piao Y, Kim J, na hB, Kim D, Baek Js, Ko MK, lee Jh, shokouhimehr M, hyeon T.
Wrap-bake-peel process for nanostructural transformation from beta-Feooh nanorods
to biocompatible iron oxide nanocapsules. nat Mater 2008; 7 :242-247.
[17] Cheng K, peng s, Xu C, sun s. porous hollow Fe(3)o(4) nanoparticles for targeted
delivery and controlled release of cisplatin. J am Chem soc 2009; 131 :10637-10644.
[18] Medarova Z, pham W, Farrar C, petkova v, Moore a. In vivo imaging of sirna delivery
and silencing in tumors. nat Med 2007; 13 :372-377.
[19] guerrero s, araya e, Fiedler Jl, arias Ji, adura C, albericio F, giralt e, arias Jl,
Fernandez Ms, Kogan MJ. improving the brain delivery of gold nanoparticles by con-
jugation with an amphipathic peptide. nanomedicine 2010; 5 :897-913.
[20] veiseh o, sun C, Fang C, Bhattarai n, gunn J, Kievit F, Du K, pullar B, lee D,
ellenbogen rg, olson J, Zhang M. specific targeting of brain tumors with an optical/
magnetic resonance imaging nanoprobe across the blood-brain barrier. Cancer res
2009; 69 :6200-6207.
[21] hombach J, Bernkop-schnurch a. Chitosan solutions and particles: evaluation of their
permeation enhancing potential on MDCK cells used as blood brain barrier model. int
J pharm 2009; 376 :104-109.
[22] Wunderbaldinger p, Josephson l, Weissleder r. Crosslinked iron oxides (Clio): a new
platform for the development of targeted Mr contrast agents. acad radiol 2002; 9
(suppl 2):s304-s306.
[23] harisinghani M, ross rW, guimaraes ar, Weissleder r. Utility of a new bolus-injectable
nanoparticle for clinical cancer staging. neoplasia 2007; 9 :1160-1165.
[24] sun s, Zeng h. size-controlled synthesis of magnetite nanoparticles. J am Chem soc
2002; 124 :8204-8205.
[25] Xu CJ, Xu KM, gu hW, Zheng rK, liu h, Zhang XX, guo Zh, Xu B. Dopamine as a
robust anchor to immobilize functional molecules on the iron oxide shell of magnetic
nanoparticles. J am Chem soc 2004; 126 :9938-9939.